Enasidenib - Servier
At a glance
- Drug Originator Agios Pharmaceuticals
- Drug Licenced by Celgene Corporation
- Drug Class Amines; Antineoplastics; Fluorinated hydrocarbons; Propanols; Pyridines; Small molecules; Triazines
- Mechanism of Action Isocitrate dehydrogenase 2 inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 9
- NDAs 1
- International Patents 111
- Patent Applications 589
Disclaimer